Pembro Plus Chemo: Practice-Changing for Nonsquamous mNSCLC

Adding pembrolizumab to chemotherapy provided significant improvement in both overall and progression-free survival; the results have been hailed as practice-changing.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply